Q32 Bio (QTTB) Debt Ratio (2023 - 2026)

Q32 Bio (QTTB) recorded quarterly Debt Ratio of 0.13 in Q1 2026, down 18.27% quarter-over-quarter from 0.16 in Q4 2025, and down 20.04% on a YoY basis from 0.16 in Q1 2025.

Q32 Bio (QTTB) Debt Ratio (2023 - 2026) Analysis & Trends

Q32 Bio's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.13 for Q1 2026.

  • In Q1 2026, Debt Ratio fell 20.04% year-over-year to 0.13; the TTM figure through Mar 2026 stood at 0.13 (down 20.04% YoY), while the FY2025 annual figure was 0.16, up 14.67% from the prior year.
  • Debt Ratio was 0.13 for Q1 2026 at Q32 Bio, down from 0.16 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.19 in Q3 2025 to a low of 0.08 in Q1 2024.
  • Historically, Debt Ratio has averaged 0.14 across 4 years, with a median of 0.13 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Debt Ratio surged 95.94% in 2025, then retreated 20.04% in 2026.
  • A 4-year view of Debt Ratio shows it stood at 0.12 in 2023, then grew by 18.13% to 0.14 in 2024, then advanced by 14.67% to 0.16 in 2025, then retreated by 18.27% to 0.13 in 2026.
  • The last three Debt Ratio figures came in at 0.13 (Q1 2026), 0.16 (Q4 2025), and 0.19 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Q32 Bio 167.59 Mn 116.84 Mn - 0.13

Historic Data

Download Data
DateValue
Mar 31, 2026 0.13
Dec 31, 2025 0.16
Sep 30, 2025 0.19
Jun 30, 2025 0.19
Mar 31, 2025 0.16
Dec 31, 2024 0.14
Sep 30, 2024 0.12
Jun 30, 2024 0.10
Mar 31, 2024 0.08
Dec 31, 2023 0.12